MRNA Moderna Inc

$MRNA $RVMD $SLS Part 2. As a Biostatistician I am going to explain it in plain English for all longs and shorts here 40+ GPS ARM patients still alive in GPS Regal Pivotal Registrational Phase 3 study = 65% =mOS was not be reached for GPS ARM patients = CURATIVE. 80Th event PR came on 10/28/26 but NO 8k was filed for exact date CRO PPD notified $SLS of 80Th Occurrence. My E mail correspondence with John Fraunces Sellas IR contact on 10/15/2026 clearly states that quiet period is strictly related to GPS Regal Phase 3. Only reason and the timeline of events connect all the dots together is Sellas has submitted Regal Phase 3 for LBA presentation at ASH 2026 on last day of LBA submission 10/28/26 and is under strict ASH Embargo policy. Since Sellas is a Public Co. ASH Embargo after written approval allows limited Regal Phase 3 Primary Top line data disclosure by the Co. in the coming days with full and final FA to be presented at the LBA session. 👇 🙏❤️‍🩹

$MRNA $SLS 🤯 I sold my $MRNA shares early 👇 I won’t make that mistake with $SLS. Buying hand over fist under $10.00. ✌️🙏❤️‍🩹

$MRNA $RVMD $SLS Part 3. My long Brothers and Sisters We are at the finish line 🏁 now and about to cross it. Remember always ““Doubt kills more dreams than failure ever will” Beware of the shorts pretending to be longs and create doubt. $SLS Will run like $MRNA and will be given standing Ovation 👏 like $RVMD at ASH 2026 Booth 138. ✌️🙏❤️‍🩹

$MRNA $RVMD $SLS My birthday is tomorrow, and mu family and I are almost 100% in SLS. I hope for a big present! Frank

$MRNA If the stock now goes to 350 and pulls back 80 points, please don't say you were right about something. As former president of the Bear market foundation of America, there's a reason I'm the former president. Even stocks that are virtually worthless tend to go up just enough to crush shorts. Shorts go broke and then they finally go down. This one's something extra special. It actually gives you a few chances to get short and make some money but every time you've overstayed your welcome you've managed to give it all back and then some. What are you not seeing here? I'm rooting for the shorts now that I don't own the stock anymore. I hope it goes to zero but if you're not seeing the stock based on your blinding rage just move on it's a lot easier. Admit you got it wrong and move on.

$MRNA I’m a bull but yesterday i saw multiple rejections at 265 ,so because of this there is a strong possibility that we are already witnessing an ABC correction especially if 250-253 support doesn’t hold: wave A concluded at 225 (approximately a 50% retracement from the impulse high 273, and the start of the impulse at 178). I assume that wave B that started at 225 also concluded around 265; in this scenario, wave C has already begun and, in most cases, ends with a 61.8% retracement or around 212, so be careful

$MRNA The balance sheet deserves particular scrutiny: Moderna's cash position benefited from $2.6 BILLION in net financing proceeds. Borrowed capital is not operating profit. My bearish technical roadmap: $275 → $258 → $243 → $237 → $230. Below that, I'm watching $217 → $208 → $201 → $194 as extended repricing levels, not guaranteed destinations. A sustained breakout above $282 would challenge this reversal thesis. THE REAL RISK AT $280 ISN'T THAT MODERNA HAS NO FUTURE. IT'S THAT INVESTORS MAY BE PAYING TOO MUCH FOR A FUTURE THAT HAS YET TO FULLY ARRIVE. YOU CAN BELIEVE IN THE COMPANY AND STILL QUESTION THE PRICE. $MRNA #Bearish #Biotech

$MRNA Hopefully, the moderna CEO was caught sleeping with anyone from the WUHAN lab in China. That is about the only thing that could take this down!

$MRNA Where are all the bulls this morning? They on a cattle truck going to the slaughter house. . ..

$MRNA since since 10/29 it has risen $100 and has only gone up every day (technically two red days between 176 and 280 yesterday ) Algos will keep trading trading the momentum and gamma/delta feedback loop until twap, vwap, and options no longer hit their model. Algos are not creative with this stock. It drops first and then you litterally see the the switch and run up and then it trades in a small box the rest of the day.

$MRNA people still don’t understand. Even through they WANT MRNA to drop, it won’t! The blip when results were leaked was nervous bot. This is going to provide a whole new way to attack cancer! Like antibiotics for bacteria!

$MRNA As you may recall, the 265–268 range was very strong resistance on Friday; today, that resistance has turned into support, so following the sharp bullish surge up to 280, testing this area is quite normal.

$MRNA Another Moderna victory, again and again. Rest up shorts and try to think about something else.

$MRNA lmao this Is nuttery. Estimated 2027 revenue under 3 billion...market cap 110 billion. 40x SALES lmao

$MRNA the strength looks incredible until you look at the volume and order flow… more $$ of calls being traded than shares. Real question is how is there so little liquidity? Either way, nothing but air below for $200+ at this point.

$MRNA Bears, stop betting against a cancer cure 😂 This will rise until there’s a vaccine or the study that no one will ever win against cancer. You don’t have to like Moderna, but you have to see the thing behind this

$MRNA sucks to have miss this one. Everyone was focused on AI and this gem 💎 kept minding its own business in its own lane. Great job 👏

$MRNA is up ~750% this year on cancer-vaccine narrative and one strong data readout.Under the hood: first 9 months of 2026 saw ~$2.7B in operating cash burn. The $8B cash figure only looks robust after a $2.6B convertible note raise. Interest income on the treasury pile is currently a meaningful contributor — that support weakens if rates fall further.Since the stock crossed ~$150, President Stephen Hoge has sold ~$29M worth of shares (at averages from ~$145 to ~$217), with additional sales from the CFO and CLO. Nearly all under 10b5-1 plans. No meaningful insider buying.R&D is being reduced while the company still competes in a crowded flu vaccine market. The price has run far ahead of cash flow, competitive reality, and the actual pace of pipeline conversion. The story is doing the work. The numbers are not.

$MRNA 7th attempt for $280 on the day, if we can hold going into close, there will be another leg up!

$MRNA When you realize pfizer does 16billion in sales with a market cap of 168 billion. But Moderna has 1.31 billion in sales with a market cap of 111 billion…. At 360/ share they’re about equal in market cap. So if Moderna reaches an ATH it’s almost as big as one of the largest biotech companies in the world!